TIDMERGO

RNS Number : 0930A

Ergomed plc

28 May 2021

PRESS RELEASE

Ergomed to Present at Jefferies Virtual 2021 Healthcare Conference

Guildford, UK - 28 May 2021: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the pharmaceutical industry, today announces that Richard Barfield, Chief Financial Officer of Ergomed, will present at the Jefferies Virtual Healthcare Conference at 1pm BST on 2 June 2021.

A live webcast of the presentation will be available on Ergomed's website, here:

https://www.ergomedplc.com/investor-relations/reports-and-presentations/

ENDS

Enquiries:

 
 Ergomed plc                                           Tel: +44 (0) 1483 402 
                                                                         975 
 Miroslav Reljanović (Executive Chairman) 
 Richard Barfield (Chief Financial Officer) 
 
 Numis Securities Limited                          Tel: +44 (0) 20 7260 1000 
 Freddie Barnfield / Matthew O'Dowd (Nominated 
  Adviser) 
 James Black (Broker) 
 
 Consilium Strategic Communications                Tel: +44 (0) 20 3709 5700 
 Chris Gardner / Matthew Neal                    ergomed@consilium-comms.com 
 Angela Gray / Lucy Featherstone 
 
 

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO). For further information, visit: http://ergomedplc.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCSEWFIWEFSEEI

(END) Dow Jones Newswires

May 28, 2021 02:00 ET (06:00 GMT)

Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Abr 2022 a May 2022 Haga Click aquí para más Gráficas Ergomed.
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De May 2021 a May 2022 Haga Click aquí para más Gráficas Ergomed.